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• pneumoconiosis
• drug-induced ILD 
• HP
ENVIRONMENTAL AND OCCUPATIONAL
INTERSTITIAL LUNG DISEASES
• Pneumoconiosis inhalation of mineral dusts
• silica
• coal dust
• Asbestos
• HP inhalation of organic dusts
• Large particles may get trapped in the nose or large airways, 
• but very small ones may reach the lungs.
• There, some particles dissolve and may be absorbed into the 
bloodstream; 
• most solid particles that do not dissolve are removed by the body's 
defenses .
Fate of inhaled particles
Body’s defense mechanism
 The body has several means of getting rid 
of inhaled particles. 
 In the airways, an accumulation of 
secretions (mucus) coats particles so that 
they can be coughed up more easily.
 Additionally, tiny cells lining the airways 
(cilia) are able to brush inhaled particles 
upward, out of the lungs. 
 In the small air sacs of the lungs (alveoli), 
special scavenger cells (macrophages) 
engulf most particles and render them 
harmless.
Alveolar space
Phagocytosis
Nature of inhaled particles
 Many different kinds of particles 
can harm the lungs. 
 Some are organic, 
 such as grain dusts, cotton dust, 
or animal dander.
 Some are inorganic, 
 such as asbestos, and silica.
Organic dust
Inorganic dust
Effects of inhaled particles
 Different types of particles produce 
different reactions in the body. 
 Some particles  can cause allergic 
reactions, such as hay fever-like 
symptoms or a type of asthma.
 Other particles cause harm not by 
triggering allergic reactions but by 
being toxic to the cells of the 
airways and air sacs in the lung. 
Effects of inhaled particles
 Some particles, such as quartz dust 
and asbestos, may cause chronic 
irritation that can lead to scarring of 
lung tissue (pulmonary fibrosis). 
 Certain toxic particles, such as 
asbestos, can cause lung cancer, 
especially in smokers, or cancer of the 
lining of the chest and lung 
(mesothelioma), regardless of the 
person's smoking history. 
Pathogenesis of Pneumoconiosis
Fibrogenic 
dust e.g silica 
and asbestos 
produce 
progressive 
fibrosis in the 
lung 
Lung function assessment
PNEUMOCONIOSIS
• eﬀects of accumulation of mineral dusts in the lungs; 
• the typical reaction is fibrosis
• Risk and extent 
• intensity and cumulative amount of exposure over time 
• Prevention 
• occupational safeguards 
• case of asbestos, legislative bans on use 
• no eﬀective treatments for these diseases
SILICOSIS
• Exposure to crystalline-free silica
• Inﬂamatory and fibrotic reaction 
• Silicotic nodule
• Occupations
• Mining 
• Stone cutting  
• Carving 
• Polishing  
• Foundry work  
• Abrasive clearing (e.g., sandblasting)  
• exposure is usually chronic (over years)  
• acute disease in the setting of heavier short-term exposures
 Silicosis is permanent 
scarring of the lungs
caused by inhaling silica 
(quartz, SiO2) dust. 
 It is a slowly progressive, 
nodular, fibrosing 
pneumoconiosis
Thickened pleura
Fibrosis
Occupational Exposure to Silica
 Silicosis, the oldest known occupational 
lung disease, develops in people who have 
inhaled silica dust for many years. 
 Silica is the main constituent of sand, so 
exposure is common among:
 metal miners,        
 sandstone and granite cutters,
 foundry workers, 
 and potters.
Clinical Varieties of silicosis
 Chronic silicosis
 Commonest form
 Nodular opacities
 Appears after 15 years or more of exposure
 Accelerated silicosis
 Appears after 5 – 10 years
 Similar to Chronic form
 Due to exposure to high concentration of silica
 Acute silicosis
 Due to massive exposure to very fine silica particles
 It causes alveolar proteiniosis , fatal, appears within 5 
years of exposure
Pathogenesis of silicosis
 When inhaled, silica dust passes into the 
lungs, and scavenger cells such as 
macrophages engulf it.
 Enzymes released by the scavenger cells 
cause the lung tissue to scar. 
 At first, the scarred areas are tiny round lumps
(simple nodular silicosis), but eventually they 
may combine into larger masses (complicated 
silicosis, PMF). 
Pathology of Silicosis
Silicotic nodulesLung fibrosis
Thickened pleura
Pathology of silicosis
Early lesions are nodules
More fibrous tissue , less cells
It is composed of lamellae of collagen
It contains dust particles, carbon
(Onion shape appearance)
Silicotic nodule
Pathology of silicosis
Initial lesions start 
first in the middle and 
upper parts of  the 
lung as small tiny 
nodules, 
then spread to the rest 
of  the lung
Symptoms and Diagnosis
An abnormal cross- section
specimen of the lung shows large
black nodules (arrows). This
finding is seen in silicosis caused
by exposure to silica dust. A
normal cross-section specimen of
the lung is shown on the right for
comparison
 Usually, symptoms appear only after 20 or more years of 
exposure to the dust.
 However, in occupations such as sandblasting, tunneling, and 
manufacturing abrasive soaps, in which high levels of silica 
dust are produced, symptoms may appear in less than 10 years
Symptoms and Diagnosis
 The least serious type of lung disease from silica 
is simple nodular silicosis.
 People with simple nodular silicosis usually have 
no trouble breathing, but they may cough ( dry).
 They may produce sputum (also called phlegm) 
when their large airways are inflamed due to 
infection or due to smoking.
Symptoms and Diagnosis
 People who have the more serious type, 
complicated silicosis, may cough, 
produce sputum, and have severe 
shortness of breath. 
 At first, the shortness of breath may 
occur only during exercise, but 
eventually it occurs even during rest. 
 Breathing may worsen for years after the 
person stops working with silica. 
Symptoms and Diagnosis
 The lung damage strains the right side of the 
heart and can lead to a type of heart failure 
(called cor pulmonale), a condition which 
may be fatal
 Also, when exposed to the organism that 
causes tuberculosis, people with silicosis are 
many times more likely to develop 
tuberculosis than people without silicosis.
Diagnosis of Silicosis
 Positive History of exposure to free silica dust
 Early dry irritant cough
 Later, shortness of breath
Diagnosis of Silicosis: Lung function
Restrictive impairment
Silicosis
Diagnosis of Silicosis: CXR
 Nodular opacities
Diagnosis of Silicosis: CXR
Nodular opacities
Diagnosis of Silicosis: CXR
Coalescence of opacities
PMF
Angle’s wings
Diagnosis of Silicosis: CXR
HRCT
Diagnosis of Silicosis: CXR
Egg shell appearance 
of hilar lymph nodes
Diagnosis of Silicosis: CXR
 Tuberculosis is the most 
common complications 
among workers with 
silicosis
Prevention and Control
 Controlling silica dust in the workplace is 
key to preventing silicosis. 
 When dust cannot be controlled, as may be 
true in the sandblasting industry, workers 
should wear protective gear, such as hoods 
that supply clean external air or special asks 
that efficiently filter out the tiny particles. 
 Such protection may not be available to all 
people working in a dusty area (for example, 
painters and welders), so whenever possible, 
abrasives other than sand should be used.
Prevention and Control
 Workers exposed to silica dust should 
have regular chest x-rays —every 6 
months for sandblasters and every 2 to 5 
years for other workers—so that problems 
can be detected early. 
 If the x-rays show silicosis, a doctor will 
probably advise the worker to avoid 
continued exposure to silica
Treatment
 Silicosis cannot be cured, but its progression can be 
slowed if exposure to silica is avoided, especially at 
an early stage of the disease. 
 A person who has difficulty breathing may benefit 
from the treatments used for chronic obstructive 
pulmonary disease, such as drug therapy to keep the 
airways open and free of mucus. 
 Because people with silicosis have a high risk of 
developing tuberculosis, they should have regular 
checkups that include a tuberculosis skin test

ACUTE SILICOSIS 
• pulmonary alveolar proteinosis
• accumulation of surfactant in the alveolar spaces
little as 10 months of exposure
CHRONIC SILICOSIS 
• nodular silicosis
• asymptomatic unless the patient is also exposed to tobacco
• Progressive massive fibrosis
• extensive bilateral apical fibrosis 
SILICOSIS
• dyspnea 
• Relatively asymptomatic 
• Abnormal chest radiograph
• uncomplicated silicosis show upper lobe nodular opacities
• progressive massive fbrosis
• architectural distortion of the upper lobes
• Hilar node enlargement 
• accompanied by eggshell nodal calcifcation
SILICOSIS
PULMONARY FUNCTION TESTS 
• in simple nodular silicosis 
• normal 
• mixed obstructive or restrictive patern
• progressive massive fibrosis 
• severe restriction and hypoxemia  
• elevated risk for tuberculosis 
• screened for latent tuberculosis infection
• association between silicosis and rheumatoid arthritis
• and scleroderma
COAL WORKER’S PNEUMOCONIOSIS 
• uncommon cause of pulmonary fibrosis
• coal dust and graphite
• underground mines
• formation of pigmented lesions in the lung surrounded by emphysema, 
• coal macules 
• Progressive massive fibrosis 
• chronic cough usually productive
• bronchitis related to coal exposure or to tobacco
• chest radiograph shows 
• diﬀuse, small, rounded opacities
• with silicosis, there is an association with rheumatoid arthritis.

CAPLAN’S SYNDROME 
• multiple, large, sometimes cavitary lung nodules 
• Seropositive rheumatoid arthritis 
• after coal dust exposure
Caplan’s 
syndrome 
first described in coal miners 
But subsequently in patients with silicosis
Asbestos fibers
Asbestos: Types
Serpentine
(93% of commercial use)
Amphibole
(7% of commercial use)
Chrysotile
Actinolite, Amosite,  
Anthophyllite, Crocidolite, 
Richterite, Tremolite
Asbestos
Asbestosis
 It is diffuse fibrosis of the lung 
parenchyma
 Asbestos fibers are highly 
resistant to heat, acids and 
chemicals
 Used to be widely used in 
industries
 Banned from use  globally since 
1973 because it is high 
carcinogenic
Occupational exposure
 Workers in car industry (brake 
manufacture)
 Workers making insulation
 Workers in ship building
 Workers who demolish buildings
that have insulation containing
asbestos are at increased risk. 
 The more a person is exposed to 
asbestos fibers, the greater the risk of 
developing an asbestos-related disease.
ASBESTOSIS
 Asbestosis is widespread 
scarring of lung tissue caused 
by breathing asbestos dust. 
 Asbestos is composed of 
fibrous mineral silicates of 
different chemical 
compositions. 
 When inhaled, asbestos fibers 
settle deep in the lungs, 
causing diffuse fibrosis.
A microscopic specimen of a cell from 
the lungs shows the presence of an 
asbestos fiber with a mineral coating. 
This patient worked in a shipyard for 
many years
ASBESTOSIS
 Asbestos inhalation also 
can cause the two layers 
of membrane covering 
the lungs (the pleura) to 
thicken; these thickenings 
are called pleural plaques. 
 These plaques do not 
become cancerous
Diaphragmatic plaque
Macrophage engulfing 
asbestos fiber
ASBESTOSIS
 Asbestos also causes cancer in the 
pleura, called mesothelioma, or in 
the membranes of the abdomen, 
called peritoneal mesothelioma. 
 In the United States, asbestos is 
the only known cause of cancerous 
(malignant) mesothelioma. 
 Smoking is not a cause of 
cancerous mesothelioma 
Tumor
lung
Mesothelioma
 An abnormal chest x-ray 
shows a tumor (arrow) in 
the lung.
 A normal chest x-ray is 
shown on the right for 
comparison; the heart 
(H), lungs (L), vertebrae 
(v), and collarbone (C) 
can be seen.
 Asbestos can also cause lung cancer. Lung cancer from 
asbestos is related in part to the level of exposure to asbestos 
fibers.
 however, among people with asbestosis, lung cancer occurs 
most commonly in those who also smoke cigarettes, 
particularly those who smoke more than a pack a day .
cancer
Pathology of Asbestos Related Diseases
Diffuse interstitial fibrosis starting 
at the base of  the lung
Thickening of  the pleura
Pathology of Asbestos Related Diseases
Diffuse fibrosis
starting at the base of  the lung
“Honey comb appearance”
Pathology of Asbestos Related Diseases
Asbestos bodies:
Fibers my be coated with
hemosiderin and undergoes
degeneration and form bodies
 Drum stick appearance
 Rods
 Dumple shaped
Pathology of Asbestos Related Diseases
Parietal pleural plaques Diaphragmatic pleural plaques
Usually asymptomatic
Pathology of Asbestos Related Diseases
Bronchogenic  
Carcinoma Mesthothelioma
Pathology of Asbestos Related Diseases
Clubbing of  the Fingers 
which reflects chronic 
hypoxic lung disease
Asbestos related diseases
 Diseases are:
 Interstitial pulmonary fibrosis (asbestosis)
 Bronchogenic carcinoma
 Pleural Effusions
 Fibrous plaques
 Pleural fibrosis
 Mesotheliomas (malignant tumor of pleura and peritoneum)
 Laryngeal (colon?) neoplasms
Asbestos-Associated Diseases
• Respiratory diseases: 
– Parenchymal asbestosis
– Asbestos-related pleural abnormalities
– Lung carcinoma
– Pleural mesothelioma
• Nonrespiratory diseases:
– Peritoneal mesothelioma
– Possibly, other extrathoracic cancers
– Rarely, cor pulmonale or constrictive pericarditis
Symptoms
 Symptoms of asbestosis appear gradually only after large 
areas of the lung become scarred.
 The scarring causes the lungs to lose their elasticity. 
 The first symptoms are a mild shortness of breath and a 
decreased ability to exercise. 
Diagnosis of asbestosis
 Positive occupational history of 
exposure to asbestos dust
 Shortness of breath
 Cyanosis
 Clupping of the fingers
 End inspiratory crepitation
Parenchymal Asbestosis
• Diffuse interstitial fibrosis with:
– Restrictive pattern of disease on pulmonary 
function testing (but can see mixed pattern)
– Impaired gas exchange
– Progressive exertional dyspnea
• Radiographic changes: >10 years
• Latency period: 20-40 years
Asbestos-Related Pleural Abnormalities
• Four types of abnormalities:
– Pleural plaques
– Benign asbestos pleural effusions
– Diffuse pleural thickening
– Rounded atelectasis
• Mostly asymptomatic, though some 
can cause dyspnea or cough
• Latency periods: 10-30 years 
(shorter latency is for pleural effusion)
Diagnosis of asbestosis: CXR
Pleural plaques
Asbestosis
Asbestosis
Prevention and treatment
 Diseases caused by asbestos inhalation can be prevented by 
minimizing asbestos dust and fibers in the workplace. 
 Because industries that use asbestos have improved dust control, fewer 
people develop asbestosis today, 
 but mesotheliomas are still occurring in people who were exposed as 
many as 40 years ago. 
Malignant Pleural Mesothelioma
• Tumor arises from the thin serosal 
membrane surrounding the lungs
• Rapidly invasive
• Rare, although incidences are 
increasing
• Long latency period: Usually 30-40 
years
Malignant Pleural Mesothelioma
• shortterm asbestos exposures of ≤1–2 years, 
occurring up to 40 years in the past
• >80% of mesotheliomas may be associated 
with asbestos exposure
Clinical Presentation
Disease Signs and Symptoms
Parenchymal 
Asbestosis
• Insidious onset of dyspnea on exertion
• Fatigue
Asbestos-Related 
Pleural 
Abnormalities
• Usually: None 
• Sometimes: Progressive dyspnea and intermittent 
chest pain (depending on the type of pleural 
abnormality)
Lung Cancer • Usually: None (until later stages) 
• Sometimes: Fatigue, weight loss, or chest pain
Mesothelioma • Usually: None (until later stages)
• Sometimes: Dyspnea, chest pain, and fatigue
Physical Examination
• Focus on lungs, heart, digits, and 
extremities
• Pulmonary auscultation to detect 
bibasilar inspiratory rales 
(not always present)
• Observation of other signs, such as 
clubbing of the fingers and cyanosis
CHRONIC EXPOSURE TO ASBESTOS
• inhaled asbestos fibers              deposited in the lungs
• small fibers may be phagocytosed and cleared through lymphatics 
• longer fibers are often retained
• Asbestos exposure 
• pleural disease characterized by pleural plaques, eﬀusion, and fibrosis
• not necessarily aﬀect the lung parenchyma
• asbestosis, with interstitial lung fibrosis resulting from asbestos exposure
ASBESTOSIS
• gradual onset of dyspnea
• risk and severity extent and duration of exposure
• reaction to retained asbestos fibers in the lung
• similar to those for restrictive lung diseases such as IPF
• detection of significant pleural disease
distinguishing 
from other 
ILDs
DIAGNOSIS
• history of exposure 
• concomitant pleural plaques 
• lower lobe predominant fibrotic changes 
• Tissue specimens  Asbestos bodies 
DIAGNOSIS
• Asbestos exposure increases the incidence of malignancy
• lung carcinoma 
• Mesothelioma
• No specifc treatment for asbestosis exists
BERYLLIOSIS
• exposure to beryllium
• rare metal useful in modern, high-technology industries
• acute chemical bronchitis and pneumonitis
• chronic beryllium disease
• multisystemic granulomatosis that is difcult to distinguish from sarcoidosis
DISTINGUISH FROM SARCOIDOSIS
DIAGNOSIS
• history of exposure
• histologic examination
• laboratory confirmation
• beryllium lymphocyte proliferation 
• Corticosteroids 
• avoid further exposure to beryllium
HYPERSENSITIVITY PNEUMONITIS
DEFNITION AND EPIDEMIOLOGY
• HP (formerly called extrinsic allergic alveolitis) 
• common ILD 
• exaggerated immune reaction in the alveoli and small airways 
• various small, inhaled organic antigens in sensitized individuals
HP
HP
• Potential sensitizing antigens are diverse
• bacterial, fungal, and animal proteins to low-molecular-weight chemicals 
• occupational forms of this disease (e.g., paprika spliter’s lung)
• More exposures may occur in everyday life
• hot tub water or to antigens from pet birds
Farmer’s Lung 
exposure to moldy hay
thermophilic actinomycetes
PATHOLOGY
• Abnormally exuberant immune response to inhaled antigens 
• organic molecules
• small chemical compounds
• Isocyanates
• susceptible host
• unclear 
• genetic and environmental factors (e.g., pesticide exposure)
PATHOLOGY
• Smokers are less likely than nonsmokers to develop HP
• more severe disease course if HP does occur
• After exposure to an antigen, a susceptible individual 
• alveolitis with inﬂux of neutrophils and lymphocytes
• TH1-type immune response then leads to granuloma formation
develops
LUNG BIOPSY 
• granulomatous inﬂammation with poorly formed granulomas 
• giant cells
• interstitial chronic inﬂammation 
• bronchiolocentric component, and bronchiolitis
• chronic or end-stage disease, fibrosis occurs
• UIP or NSIP pattern  
CLINICAL PRESENTATION
ACUTE HP
• several hours ﬂulike illness featuring 
• Fever
• Chills
• Cough
• Dyspnea
• Malaise
• lasts for up to 24 hours 
• farmer’s lung from exposure to thermophilic actinomycetes
CLINICAL PRESENTATION
SUBACUTE AND CHRONIC HP 
• repeated or prolonged lower-level antigen exposure
• chronic dyspnea and cough 
• progression to pulmonary fibrosis 
• pigeon breeder’s lung 
HP
• Acute HP 
• Febrile
• Diﬀuse wheezes 
• Chronic HP
• Crackles  
• Clubbing
• Hypoxemia with exertion 
• hypoxemia at rest in chronic fibrotic HP
• PFT usually show a restrictive patern
• abnormal gas exchange
• obstructive or mixed paterns
HP
• CXR: nonspecifc infiltrates in the middle and upper lung fields 
• normal in acute disease
• CT scanning in acute disease
• ground-glass opacities
• centrilobular nodules
• mosaic atenuation and air trapping paterns resulting from airway obstruction  
• Chronic HP 
• architectural distortion with traction bronchiectasis and honeycombing 




HP
• Emphysema occurs in some cases of advanced farmer’s lung.
• BAL 
• lymphocytic alveolitis, with CD4+ T-lymphocyte predominance
• precipitating antibodies to the oﬀending antigen
• not sufficiently sensitive or specific for diagnosis
• specifc antigen?
DIAGNOSIS AND DIﬀERENTIAL 
DIAGNOSIS
• appropriate exposure, clinical history, BAL, and HRCT imaging 
• lung biopsy 
• necessary for confirmation, especially in subacute and chronic HP  
• Thransbronchial biopsy 
• surgical lung biopsy

DIAGNOSIS AND DIﬀERENTIAL 
DIAGNOSIS
• diﬀerential diagnosis 
• Acute HP
• Acute viral infection 
• Chronic HP
• IPF 
• NSIP
• Sarcoidosis 
TREATMENT
• Clinical improvement often occurs in the hospital setting 
• relapse may occur after discharge
• Corticosteroids can relieve symptoms in the acute phase
• long-term efficacy in chronic forms? 
• Identification of the cause of HP
• avoidance of exposure to the antigen in chronic hp
• financially or psychologically challenging 
• occupational, pet, or residential exposures
• For advanced HP with fibrosis, lung transplantation 
PROGNOSIS
• Acute HP usually has a good prognosis
• Chronic HP can lead to end-stage pulmonary fibrosis and death

